Ex-JPMorgan traders found guilty in spoofing case
By 
Jeff Dale2022-08-11T19:41:00
Two former precious metals traders at JPMorgan Chase were found guilty of fraud, attempted price manipulation, and spoofing as part of a near decade-long market manipulation scheme involving thousands of illegal trades.
A federal jury in the Northern District of Illinois convicted Gregg Smith, a former executive director and trader on JPMorgan’s precious metals desk in New York, and Michael Nowak, a former managing director at JPMorgan’s global precious metals desk, the Department of Justice (DOJ) announced in a press release Wednesday.
The guilty verdicts follow a $920 million fine against JPMorgan in September 2020 levied by the Commodity Futures Trading Commission (CFTC), which worked in conjunction with the Securities and Exchange Commission and DOJ.
Related articles
-
News BriefEx-JPMorgan precious metals traders sentenced in spoofing case
Two former precious metals traders at JPMorgan Chase were sentenced after being convicted a year ago for fraud, attempted price manipulation, and spoofing.
-
ArticleFifth JPMorgan Chase metals trader convicted of fraud in DOJ spoofing case
A former JPMorgan Chase and Credit Suisse precious metals trader was convicted of fraud, wrapping up a long-running Department of Justice investigation into the manipulation of the precious metals markets from 2008-16.
-
Article
Judge: Ex-JPMorgan compliance exec’s retaliation claims credible for trial
A jury could conclude allegations made by a former JPMorgan Chase compliance executive who said she was fired for blowing the whistle have merit, a federal judge ruled.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”